These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 5426192)
21. [Detection and prevention of drug-induced lesions. 20 years' experiences in the Drug Committee of the German Medical Society]. Homann G Internist (Berl); 1973 Jan; 14(1):19-24. PubMed ID: 4576792 [No Abstract] [Full Text] [Related]
22. [Responsibility for drug reactions]. Naess K Nord Med; 1975 Mar; 90(3):65-6. PubMed ID: 1153254 [No Abstract] [Full Text] [Related]
23. Adverse drug reaction program using pharmacist and nurse monitors. Miwa LJ; Randall RJ Hosp Formul; 1986 Nov; 21(11):1140-3, 1146. PubMed ID: 10279322 [TBL] [Abstract][Full Text] [Related]
24. The Drug Spotlight Program. Aagaard GN J Assoc Hosp Med Educ; 1978; 1st Quarter():58-60. PubMed ID: 10307276 [No Abstract] [Full Text] [Related]
25. A survey of adverse drug reaction reporting programs in select hospitals. Case RL; Guzzetti PJ Hosp Pharm; 1986 May; 21(5):423-6, 431-4, 438. PubMed ID: 10276799 [TBL] [Abstract][Full Text] [Related]
26. [Registration of drug adverse effects and complications in 1970-1971]. Skobba TJ; Lunde PK Tidsskr Nor Laegeforen; 1972 Aug; 92(24):1537-40. PubMed ID: 5076543 [No Abstract] [Full Text] [Related]
27. Computer-assisted use of tracer antidote drugs to increase detection of adverse drug reactions: a retrospective and concurrent trial. Dalton-Bunnow MF; Halvachs FJ Hosp Pharm; 1993 Aug; 28(8):746-9, 752-5. PubMed ID: 10127575 [TBL] [Abstract][Full Text] [Related]
28. [Congenital malformations and drugs]. Tidsskr Nor Laegeforen; 1970 Mar; 90(5):505. PubMed ID: 5463977 [No Abstract] [Full Text] [Related]
29. [Not for the pharmaceutical institute: Stake on clinical pharmacology. Regional rationalization is profitable]. Lakartidningen; 1970 Jan; 67(5):483-6. PubMed ID: 5426359 [No Abstract] [Full Text] [Related]
30. Adverse drug reaction reporting system: developing a well-monitored program. Kilarski DJ; Ziegler B; Coarse J; Buchanan C Hosp Formul; 1986 Sep; 21(9):949-52. PubMed ID: 10289704 [TBL] [Abstract][Full Text] [Related]
31. [Role of drug information]. Lunde PK Tidsskr Nor Laegeforen; 1977 Jan; 97(3):150-1. PubMed ID: 835120 [No Abstract] [Full Text] [Related]
32. Adverse Drug Reactions Advisory Committee: ADRAC. Report for 1977. Med J Aust; 1978 Nov; 2(11):suppl 1-2. PubMed ID: 32466 [No Abstract] [Full Text] [Related]
33. A regional adverse drug reaction programme. Farkas T Can J Hosp Pharm; 1978; 31(4):132-8. PubMed ID: 10237307 [No Abstract] [Full Text] [Related]
34. [Registration of the side effects of drugs]. Ned Tijdschr Geneeskd; 1987 Jan; 131(2):69-70. PubMed ID: 3821979 [No Abstract] [Full Text] [Related]
35. [Reports to the Committee of Adverse Drug Reactions]. Juul P Ugeskr Laeger; 1986 May; 148(22):1354-5. PubMed ID: 3727133 [No Abstract] [Full Text] [Related]
36. [Drug-induced blood dyscrasias. Reports to the Committee on Adverse Drug Reactions 1968-1983]. Jennum P; Kristensen MB Ugeskr Laeger; 1985 Aug; 147(32):2539-41. PubMed ID: 4060328 [No Abstract] [Full Text] [Related]
37. New Zealand Committee on Adverse Drug Reactions. 6th annual report. N Z Dent J; 1971 Oct; 67(310):253-62. PubMed ID: 5291449 [No Abstract] [Full Text] [Related]
38. Role of drug and therapeutics committee towards drug safety--experiences from western Nepal. Palaian S; Mishra P Kathmandu Univ Med J (KUMJ); 2005; 3(1):79-80. PubMed ID: 16401950 [No Abstract] [Full Text] [Related]
39. [Registration of adverse effects and complications]. Asdahl T Tidsskr Nor Laegeforen; 1970 Nov; 90(22):2114-5. PubMed ID: 5479234 [No Abstract] [Full Text] [Related]
40. [Systematic registration of drug side-effects]. Greiser E; Bär U; Bogenstätter P; Hartmann F; Helmstaedt D; Jacobitz K; Klaus W; May B; Melz D; Rosenkranz K; Schneider B; Stock K; Westermann E Verh Dtsch Ges Inn Med; 1974; 80():923-5. PubMed ID: 4454691 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]